Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comprehensive Study of Liver Cancer Diagnosis and Prognosis Prediction Based on Artificial Intelligence and Multimodal Data

NCT07658586 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.

NCT NCT07658586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07658586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comprehensive Study of Liver Cancer Diagnosis and Prognosis Prediction Based on Artificial Intelligence and Multimodal Data
Lead sponsor
Guangxi Medical University
Phase
Observational
Overall status
Active, not recruiting
Start date
December 1, 2025
Completion date
December 1, 2028
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, intrahepatic cholangiocarcinoma (icc), liver cancer